https://scholars.lib.ntu.edu.tw/handle/123456789/583141
DC Field | Value | Language |
---|---|---|
dc.contributor.author | SHENG-KAI LIANG | en_US |
dc.contributor.author | Chao S.-Y. | en_US |
dc.contributor.author | Li C.-C. | en_US |
dc.contributor.author | Ip K.-U. | en_US |
dc.contributor.author | Lin Y.-K. | en_US |
dc.contributor.author | Hsu C.-C. | en_US |
dc.contributor.author | Hsu P.-C. | en_US |
dc.contributor.author | Wang I.-C. | en_US |
dc.date.accessioned | 2021-09-17T03:21:18Z | - |
dc.date.available | 2021-09-17T03:21:18Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1755-1307 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068156239&doi=10.1088%2f1755-1315%2f276%2f1%2f012003&partnerID=40&md5=459079ea1854a5d14f0e5ec262f63919 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/583141 | - |
dc.description.abstract | Foxm1 is a potential transcription factor that is abundantly expressed in highly proliferative human lung cancer cells. Foxm1 also strongly correlates to lung fibrosis, epithelial-mesenchymal transition (EMT) to enhance metastatic program during the lung adenocarcinoma development. Foxm1 plays a pivotal role in controlling cell cycle phase through the G1-S-G2 checkpoint. The increasing Foxm1 and K-ras oncogene expression significantly associate with tumor growth and poor prognosis that potentially modulate patient's mortality in a subject with lung carcinoma. The genetic evidence showed that the silencing of Foxm1 resulted in the decrease in lung tumorigenesis. Thus, Foxm1 may contribute in the future as the potential target for cancer therapy by reducing lung fibrosis, EMT, and tumor cell proliferation to improve patient's survival rate. ? 2019 IOP Publishing Ltd. All rights reserved. | - |
dc.publisher | Institute of Physics Publishing | - |
dc.relation.ispartof | IOP Conference Series: Earth and Environmental Science | - |
dc.subject | Foxm1; lung adenocarcinoma; prognosis; transcription factor | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | Cell proliferation; Diagnosis; Diseases; Patient treatment; Transcription; Transcription factors; Tumors; Cell cycle phase; Epithelial-mesenchymal transition; Foxm1; Human lung cancer cells; K-ras oncogenes; lung adenocarcinoma; Potential targets; prognosis; Biological organs | - |
dc.title | Foxm1 Transcription Factor Regulates Lung Adenocarcinoma Development | en_US |
dc.type | conference paper | en |
dc.identifier.doi | 10.1088/1755-1315/276/1/012003 | - |
dc.identifier.scopus | 2-s2.0-85068156239 | - |
dc.relation.pages | 12003 | - |
dc.relation.journalvolume | 276 | - |
dc.relation.journalissue | 1 | - |
item.openairetype | conference paper | - |
item.openairecristype | http://purl.org/coar/resource_type/c_5794 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.orcid | 0000-0003-3486-2293 | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.